Advertisement
U.S. markets open in 2 hours 24 minutes
  • S&P Futures

    5,306.50
    -1.75 (-0.03%)
     
  • Dow Futures

    40,143.00
    -1.00 (-0.00%)
     
  • Nasdaq Futures

    18,496.50
    -7.25 (-0.04%)
     
  • Russell 2000 Futures

    2,137.00
    -1.40 (-0.07%)
     
  • Crude Oil

    82.19
    +0.84 (+1.03%)
     
  • Gold

    2,234.00
    +21.30 (+0.96%)
     
  • Silver

    24.81
    +0.06 (+0.23%)
     
  • EUR/USD

    1.0794
    -0.0035 (-0.32%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.99
    +0.21 (+1.64%)
     
  • GBP/USD

    1.2619
    -0.0019 (-0.15%)
     
  • USD/JPY

    151.3700
    +0.1240 (+0.08%)
     
  • Bitcoin USD

    70,715.58
    +682.36 (+0.97%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,957.07
    +25.09 (+0.32%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Drugmaker Lilly's Elanco animal health unit files for IPO

Aug 2 (Reuters) - Drugmaker Eli Lilly's Elanco Animal Health division filed for an initial public offering with U.S. regulators on Thursday.

Lilly, which expects to own less than 20 percent in the new company, said separately the number of shares in the offering were yet to be finalized.

Lilly said last month it would take Elanco public, marking the end of a nine-month review that weighed options for the unit.

Elanco would apply to have its common stock listed on the New York Stock Exchange under the symbol "ELAN," it said in a filing https://www.sec.gov/Archives/edgar/data/1739104/000104746918005384/a2236167zs-1.htm with the U.S. Securities and Exchange Commission.

Goldman Sachs, JPMorgan and Morgan Stanley are among the underwriters for the IPO.

Elanco's proposed IPO size of up to $100 million is an estimate solely for calculating the registration fee. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)

Advertisement